$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Midostaurin use restrictions and warnings for specific populations
2026-02-01 22:25:32
Check Details
2024 Midostaurin Overseas Drug Purchase Guide
2026-02-01 22:25:32
Check Details
Midostaurin domestic launch progress in 2024
2026-02-01 22:25:32
Check Details
Midostaurin medical insurance reimbursement status in 2024
2026-02-01 22:25:32
Check Details
Current status of medical insurance and patient purchasing strategies for avatrombopag (SuKeXin)
2026-02-01 22:25:32
Check Details
Avatrombopag (Avatrombopag) Side Effects and Precautions
2026-02-01 22:25:32
Check Details
A complete guide to purchasing avatrombopag in 2024
2026-02-01 22:25:32
Check Details
Drug Encyclopedia: Detailed Description of Avatrombopag
2026-02-01 22:25:32
Check Details
How to take avatrombopag effectively
2026-02-01 22:25:32
Check Details
Is Lynparza (Lipadro) chemotherapy or a targeted drug?
2026-02-01 22:25:32
Check Details
Efficacy and application of Lynparza (Lipdroxy) tablets
2026-02-01 22:25:32
Check Details
The anti-cancer effects and possible adverse reactions of Lynparza
2026-02-01 22:25:32
Check Details
1
2
...
859
860
861
862
863
864
865
...
10238
10239
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Vosoritide Storage and Reconstitution: Refrigerate, 90-Day Room Temp, Use Within 3 Hours
2
FDA Approves Pembrolizumab for TMB-H Solid Tumors: Threshold ≥13 mut/Mb, KEYNOTE-158 Data
3
Capmatinib for METex14 NSCLC: Test First, Monitor Toxicity
4
Vosoritide Side Effects and Pre-Injection Food/Fluid: Injection-Site Reactions, Transient Hypotension
5
Ribociclib Still Allows Recurrence: HR+/HER2- Adjuvant and Advanced Use
6
Pretomanid Mechanism and BPaL Use in Drug-Resistant TB
7
Pacritinib Drug Contraindications and Precautions
8
Pomalidomide Side Effects, Risk Monitoring, and Precautions
9
Dasatinib for Ph+ Chronic Myeloid Leukemia: Dosage, Administration, and Long-Term Care
10
Obeticholic Acid 5 mg for PBC: Dosage, Risks, and Current Status
11
Acalabrutinib Monotherapy for CLL: What It Can and Cannot Do
12
Bepirovirsen for Chronic HBV Functional Cure: FDA Criteria and B-Well Data